Edit with Elementor
In this episode, host Dr. Chris Beck interviews guests Dr. Omar Chohan and Dr. Harris Chengazi about dialysis fistula declot procedures and their own experiences with various devices and strategies, including usage of pre-procedure ultrasound, heparinization, and closure techniques.
In this episode, host Dr. Chris Beck interviews guests Dr. Omar Chohan and Dr. Harris Chengazi about dialysis fistula declot procedures and their own experiences with various devices and strategies, including usage of pre-procedure ultrasound, heparinization, and closure techniques.
In this episode, host Dr. Chris Beck interviews guests Dr. Omar Chohan and Dr. Harris Chengazi about dialysis fistula declot procedures and their own experiences with various devices and strategies, including usage of pre-procedure ultrasound, heparinization, and closure techniques.
In this episode, host Dr. Chris Beck interviews guests Dr. Omar Chohan and Dr. Harris Chengazi about dialysis fistula declot procedures and their own experiences with various devices and strategies, including usage of pre-procedure ultrasound, heparinization, and closure techniques.
In this episode, host Dr. Chris Beck interviews guests Dr. Omar Chohan and Dr. Harris Chengazi about dialysis fistula declot procedures and their own experiences with various devices and strategies, including usage of pre-procedure ultrasound, heparinization, and closure techniques.
PLANO, Texas, July 28, 2023 /PRNewswire/ — Argon Medical Devices, a leading manufacturer of medical devices for interventional procedures, announces recognition as a 2023 Top Workplaces in the USA Manufacturing sector.
Recipients of the Top Workplaces Manufacturing awards are selected based on feedback from a research-backed employee engagement survey initiated by technology company, Energage. Top Workplaces Industry awards celebrate organizations that have built people-first workplace cultures within their sector. In addition, the award identifies selected organizations as an employer of choice for those seeking employment in the industry.
The employees of Argon Medical are unified in their mission to improve the lives of patients and caregivers through innovation, manufacturing, and delivery of best-in-class medical devices and superior service. The company’s culture is built on shared core values of responsiveness, respect, results, people and integrity.
“Being honored with the Manufacturing Top Workplaces award holds significant meaning for us,” said George Leondis, President & CEO, Argon Medical. “It validates our efforts to create an environment where employees feel valued, inspired, and empowered to contribute their best every day. It is a recognition of our unwavering focus on excellence, both in our products and in the experiences we create for our employees.”
PLANO, Texas, May 30, 2023 /PRNewswire/ — Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology, announced the launch of the SuperCore Advantage™ Semi-Automatic Biopsy Instrument as the newest addition to its soft tissue biopsy product portfolio in the United States.
The SuperCore Advantage is a disposable, next generation soft tissue biopsy instrument that provides a superior volume of tissue samples*. Collecting more tissue volume may increase the likelihood of an accurate diagnosis, allowing healthcare professionals to feel confident sending tissue samples to pathology for analysis. The new design is available in a full range of lengths and gauge sizes so that physicians can select the best fit device for the clinical application.
“Precise and reliable biopsies are critical in the quest for better patient outcomes,” said Dr. Paul Guzzetta, Interventional Radiologist, Advocate Christ Medical Center. “By delivering greater tissue volume, the new SuperCore Advantage provides the pathologist with the tissue needed to perform necessary diagnostic tests and determine potentially life-altering diagnoses or treatment options for patients.”
“Argon is proud of the innovation we are bringing to soft tissue biopsies. The SuperCore Advantage was designed with input from healthcare professionals to help address the clinical needs and wants of those who perform biopsies on patients at a critical crossroad in their lives,” said George Leondis, President & CEO, Argon Medical. “We are very pleased to bring this long-awaited product to market.”
“We take pride in offering a full portfolio of best-in-class soft tissue biopsy solutions for our clinician customers. Adding the SuperCore Advantage to this portfolio among other segment leaders like the BioPince Ultra® Full Core Biopsy Instrument, will fortify our reputation as a leading provider of soft tissue biopsy devices,” said Tom Younker, Senior Vice President of Global Marketing, Argon Medical.
Argon also offers the SuperCore™ Semi-Automatic, Tru-Core™ Automatic and Pro-Mag™ Ultra Biopsy Instruments.
*Date on File
PLANO, Texas, March 7, 2023 /PRNewswire/ — Argon Medical Devices, Inc., a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology, introduces the TRAVELER™ Portal Vein Access Series as the newest addition to its portal vein access product portfolio. The product line is designed to meet the challenging needs of physicians accessing the portal vein through the liver during Transjugular Intrahepatic Portosystemic Shunt (TIPS) procedures. TRAVELER supplements Argon’s notable 2021 launch of SCORPION® which also supports TIPS procedures.
TRAVELER is designed to improve component visualization and durability, which are common challenges of the TIPS procedure. “Several innovative features of the TRAVELER set make it easier to access the portal vein compared to other sets on the market. Firstly, the metal cannula is very robust, and the shaping tool allows it to be curved to great degrees without compromising component integrity. Secondly, the puncture needle is longer and seems sharper, making it easier to pass through severely fibrotic liver parenchyma and reach the portal vein, even when there is very distorted anatomy” said Dr. Donna D’Souza, an Interventional Radiologist at the University of Minnesota.
“Our mission is to improve the lives of patients and caregivers through the innovation, manufacturing, and delivery of best-in-class medical devices. Thus, we were compelled to act when we identified an opportunity to simplify complex portal vein access procedures for our customers. We are excited to launch our new TRAVELER products for this purpose and see the positive impact they have on portal access procedures and outcomes in accordance with our mission.” said George Leondis, President & CEO of Argon Medical.
The TRAVELER Series, which includes TRAVELER™16, TRAVELER™21, and TRAVELER™38, is now available in the United States and Canada. “The number of TIPS procedures performed worldwide is increasing as the incidence of liver cirrhosis grows. The advantages offered by our TRAVELER products may make these procedures more efficient for the Interventional Radiologists performing them and the patients they serve.” said Tom Younker, Senior Vice President of Global Marketing at Argon Medical.
This is the first of multiple new product launches expected from Argon Medical in 2023.
In this episode, host Dr. Chris Beck interviews interventional radiologist Dr. George Behrens about how he built a robust multidisciplinary portal hypertension clinic in a community hospital, tips for common challenges during a TIPS, and post-TIPS management.
Listen here: https://www.backtable.com/shows/vi/podcasts/222/new-tools-for-tips
FRISCO, Texas, Feb. 28, 2022 /PRNewswire/ — Argon Medical Devices, Inc., a leading manufacturer of medical devices for interventional procedures, announces its 50th anniversary. This impressive milestone speaks to the dedication of the company’s employees who take pride in the impact their contributions make on patients around the globe. Headquartered in Frisco, Texas, Argon offers a broad line of best-in-class products for Interventional Radiology, Interventional Oncology and Vascular Surgery procedures. Thanks to outstanding service, reliability, and quality, Argon maintains loyal strategic partnerships with physicians, clinicians, medical device distributors and strategic OEMs.
Argon was founded in 1972 producing procedural guidewires, gradually expanding to introduce disposable packs, special procedure kits and trays for Cardiology and Critical Care procedures.
“We have been dedicated in our mission to improve the lives of patients and caregivers for 50 years.”
In 2009, Argon’s strategic direction shifted to focus on products for Interventional Radiology. This led to further expansion of the product portfolio through acquisitions of companies and products in the interventional vascular, interventional oncology areas, including clot management, biopsy and drainage segments. More recently, the company bolstered its research and development capabilities, leading to introduction of organically developed products including the Scorpion® Portal Vein Access Series, Halo™ single-loop snares, BioPince® Ultra Full Core Biopsy Instrument, and Single- and Triple-Loop vena cava filter retrieval kits.
“As we begin 2022, there is a feeling of excitement that Argon is celebrating its 50th anniversary,” said President and CEO, George Leondis. “I am proud that we have achieved this milestone, highlighted by the tremendous growth we experienced in the last decade with the steady introduction of innovative products. We are dedicated in our mission to improve the lives of patients and caregivers through the innovation, manufacturing and delivery of best-in-class medical devices and superior service. This is what enabled our evolution from a small medical accessories company to a global leader competing with the largest players in our industry. I look forward to making our 50th year the best year, ever.”
Argon employs over 1,000 people worldwide, with manufacturing facilities in Athens, Texas, Wheeling, Illinois, Portage, Wisconsin, and Rochester, New York. The company’s products are sold worldwide through a combination of direct sales representatives and an expansive distributor network. For more information and to sign up to receive the company’s latest news and product announcements, visit argonmedical.com.
Scorpion® is a registered trademark of Hatch Medical, LLC.
FRISCO, Texas, Nov. 2, 2021 /PRNewswire/ — Argon Medical Devices, Inc., a global manufacturer of specialty devices for Interventional Radiology, Vascular Surgery, and Interventional Cardiology, formally announced the launch of two unique portal vein access sets intended for transjugular liver access in diagnostic and interventional procedures.
The SCORPION® Portal Vein Access Series addresses the common challenges physicians encounter when placing a Transjugular Intrahepatic Portosystemic Shunt (TIPS) or conducting other portal vein access procedures. The Scorpion Series includes two sets, Scorpion® and Scorpion®X, which offer improved visualization, revolutionary navigation control, and enhanced durability to augment existing procedural techniques.
The Scorpion Portal Vein Access Series utilizes a patented curve-in-curve system to offer physicians 360-degree range of motion with the needle or stylet used to access the portal vein. Each curved component can work together or independently to accurately steer the device through the liver to the intended target. Existing systems utilize only a single curve limiting the steerability of the needle or stylet. The Scorpion Series’ novel design was created by Dr. Lowell Kahn, a Vascular and Diagnostic Interventional Radiologist located in Springfield, MA., in conjunction with Hatch Medical, L.L.C.
“Establishing access to the portal venous system is often the longest and most challenging part of many procedures. This is particularly true when the liver is diseased, making the anatomy irregular. I designed the SCORPION’s independently controlled dual curves to improve the physician’s ability to navigate through liver parenchyma and reduce the number of attempts necessary to establish access to the portal vein,” said Dr. Khan.
“Argon Medical is proud to add the Scorpion Series into our product portfolio. 2021 is our ‘Year of Innovation,’ and we continue to develop and deliver innovative products to the interventional market. Launching Scorpion demonstrates our desire and ability to innovate to improve the lives of our customers and the patients they treat.” said George Leondis, CEO of Argon Medical
The Scorpion Portal Vein Access sets are currently available in the United States. Scorpion® is licensed by Argon Medical and is a trademark of Hatch Medical, L.L.C.
FRISCO, Texas, Aug. 20, 2021 /PRNewswire/ — Argon Medical Devices, Inc., a leading manufacturer of medical devices for interventional procedures, announced the commercial launch of SKATER™ Mini-Loop Drainage Catheters in the United States and the European Union.
The SKATER™ Mini-Loop is a drainage catheter placed through the skin using imaging guidance as a minimally invasive way to remove or drain an unwanted fluid collection. The SKATER™ Mini-Loop Drainage Catheter is an expansion of Argon’s SKATER™ All-Purpose and Nephrostomy drainage portfolio, and it uses a 40% smaller loop to help secure the catheter and drain fluid from smaller cavities.
“Argon’s Mission is to deliver innovative, best-in-class medical devices to improve the customer experience and the lives of their patients. We are excited to complete our SKATER™ portfolio of drainage solutions and celebrate this next launch in our Year of Innovation,” said George A. Leondis, President and CEO of Argon Medical Devices.
“The SKATER™ Mini-Loop Drainage Catheter is easily inserted and forms a tight loop formation to prevent drainage occlusion. Unlike other drainage catheters in the class, SKATER™ Mini-Loop is compatible with alcohol and has durability to resist kinking, which is important to me.” said Dr. Sujoy Menon, an Interventional Radiologist at Newark Beth Israel Medical Center. Dr. Menon and Dr. Sayed Ali, a resident of the Rutgers Medical School, were the first physicians in the United States to use the SKATER™ Mini-Loop Drainage Catheter.
Argon Medical Devices introduced several new devices in the biopsy, drainage, and vascular therapy segments in 2020, despite the global pandemic. The company refers to 2021 as its Year of Innovation because it plans to launch even more innovative new products throughout the year to help facilitate interventional vascular and oncology procedures.
